+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030- Product Image
Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030- Product Image
New

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 178 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5626281
Description Jump to:
The Oral Solid Dosage Contract Manufacturing Market was valued at USD 38.64 billion in 2024, and is projected to reach USD 54.72 billion by 2030, rising at a CAGR of 5.99%. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.
  • In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
  • In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
  • In January 2023, Catalent and Ethicann collaborated to develop Ethicann’s clinical drug pipeline using Catalent’s technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights

  • The tablets segment dominated the market with a revenue share of 32.74% in 2024. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth.
  • The controlled release segment accounted for the largest share in 2024. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future.
  • Based on end-use, the large size companies segment accounted for the largest share in 2024. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption.
  • Asia-Pacific led the global market in 2024 and is projected to witness the fastest CAGR over the forecast period. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Purchased Database
1.3.3. Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.4. Information or Data Analysis
1.4.1. Information Analysis
1.4.2. Market Formulation & Data Visualization
1.4.3. Data Validation & Publishing
1.5. Model Details
1.5.1. Commodity Flow Analysis (Model 1)
1.5.2. Top Down Market Estimation (Model 2)
1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
1.5.4. Multivariate Analysis (Model 4)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
3.3.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
3.3.1.3. Increasing Demand for Novel Therapies
3.3.1.4. Increasing Demand for One-Stop-Shop CMOs
3.3.2. Market Restraint Analysis
3.3.2.1. Strict Approval Criteria by Regulatory Authorities
3.3.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
3.3.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
3.4. Technology Landscape
3.4.1. Manufacturing Technology
3.4.2. Encapsulation Technology
3.4.3. Coating Technology
3.4.4. Packaging Technology
3.4.5. Analytical Technology
3.5. Pricing Model Analysis
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Oral Solid Dosage Contract Manufacturing Market; Product Movement Analysis
4.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Tablets
4.4.1. Tablets market estimates and forecasts, 2018-2030 (USD Million)
4.5. Capsules
4.5.1. Capsules market estimates and forecasts, 2018-2030 (USD Million)
4.6. Powders
4.6.1. Powders market estimates and forecasts, 2018-2030 (USD Million)
4.7. Granules
4.7.1. Granules market estimates and forecasts, 2018-2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Oral Solid Dosage Contract Manufacturing Market; Mechanism Movement Analysis
5.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
5.4. Immediate Release
5.4.1. Immediate release market estimates and forecasts, 2018-2030 (USD Million)
5.4.2. Delayed Release
5.4.2.1. Delayed release market estimates and forecasts, 2018-2030 (USD Million)
5.4.3. Controlled Release
5.4.3.1. Controlled release market estimates and forecasts, 2018-2030 (USD Million)
Chapter 6. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Oral Solid Dosage Contract Manufacturing Market; End Use Movement Analysis
6.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Large Size Companies
6.4.1. Large size companies market estimates and forecasts, 2018-2030 (USD Million)
6.5. Medium & Small Size Companies
6.5.1. Medium & small size companies market estimates and forecasts, 2018-2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2018-2030 (USD Million)
Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Regional Business Analysis
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Competitive scenario
7.3.2.3. Regulatory framework
7.3.2.4. U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Competitive scenario
7.3.3.3. Regulatory framework
7.3.3.4. Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Competitive scenario
7.3.4.3. Regulatory framework
7.3.4.4. Mexico oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4. Europe
7.4.1. Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.3. UK
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. UK oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory framework
7.4.4.4. France oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Competitive scenario
7.4.5.3. Regulatory framework
7.4.5.4. Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Competitive scenario
7.4.6.3. Regulatory framework
7.4.6.4. Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Key country dynamics
7.4.7.2. Competitive scenario
7.4.7.3. Regulatory framework
7.4.7.4. Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Key country dynamics
7.4.8.2. Competitive scenario
7.4.8.3. Regulatory framework
7.4.8.4. Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.4.9. Norway
7.4.9.1. Key country dynamics
7.4.9.2. Competitive scenario
7.4.9.3. Regulatory framework
7.4.9.4. Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5.3. China
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. China oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. India oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5.6. Australia
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.6. Latin America
7.6.1. Latin America oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Brazil oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Argentina oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.7. MEA
7.7.1. MEA oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.7.2. South Africa
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. South Africa oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Saudi Arabia oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. UAE oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Kuwait oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Position Analysis, 2024
8.3. Company Profiles
8.3.1. Catalent, Inc.
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Lonza
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Aenova Group
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Boehringer Ingelheim International GmbH
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Jubilant Pharmova Limited
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Patheon Pharma Services
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Recipharm AB.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Corden Pharma International
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Siegfried Holding AG
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Piramal Pharma Solutions
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Service benchmarking
8.3.10.4. Strategic initiatives
8.3.11. AbbVie Contract Manufacturing
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Service benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Next Pharma AB
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Service benchmarking
8.3.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Oral Solid Dosage Contract Manufacturing Market, by Region, 2018-2030 (USD Million)
Table 3 North America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 4 North America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 5 North America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 6 U.S. Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 7 U.S. Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 8 U.S. Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 9 Canada Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 10 Canada Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 11 Canada Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 12 Mexico Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 13 Mexico Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 14 Mexico Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by Region, 2018-2030 (USD Million)
Table 16 Europe Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 17 Europe Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 18 Europe Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 19 UK Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 20 UK Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 21 UK Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 22 Germany Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 23 Germany Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 24 Germany Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 25 France Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 26 France Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 27 France Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 28 Italy Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 29 Italy Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 30 Italy Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 31 Spain Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 32 Spain Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 33 Spain Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 34 Denmark Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 35 Denmark Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 36 Denmark Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 37 Sweden Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 38 Sweden Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 39 Sweden Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 40 Norway Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 41 Norway Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 42 Norway Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by Region, 2018-2030 (USD Million)
Table 44 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 45 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 46 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 47 China Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 48 China Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 49 China Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 50 India Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 51 India Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 52 India Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 53 Japan Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 54 Japan Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 55 Japan Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 56 Australia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 57 Australia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 58 Australia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 59 South Korea Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 60 South Korea Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 61 South Korea Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 62 Thailand Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 63 Thailand Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 64 Thailand Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018-2030 (USD Million)
Table 66 Latin America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 67 Latin America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 68 Latin America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 69 Brazil Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 70 Brazil Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 71 Brazil Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 72 Argentina Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 73 Argentina Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 74 Argentina Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by Region, 2018-2030 (USD Million)
Table 76 MEA Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 77 MEA Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 78 MEA Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 79 South Africa Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 80 South Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 81 South Africa Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 85 UAE Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 86 UAE Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 87 UAE Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
Table 88 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Product, 2018-2030 (USD Million)
Table 89 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018-2030 (USD Million)
Table 90 Kuwait Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Oral solid dosage contract manufacturing market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Commodity flow analysis
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD model sizing & forecasting
Figure 10 Market formulation & validation
Figure 11 Market snapshot
Figure 12 Segment snapshot
Figure 13 Segment snapshot
Figure 14 Competitive landscape snapshot
Figure 15 Parent market outlook, 2024 (USD Million)
Figure 16 Ancillary market outlook, 2024 (USD Million)
Figure 17 Oral solid dosage contract manufacturing market dynamics
Figure 18 Product approvals in the U.S. and EU per year (2024)
Figure 19 Porter’s five forces analysis
Figure 20 PESTEL analysis
Figure 21 Oral solid dosage packaging types in the U.S., 2024 (volume percentage share %)
Figure 22 Oral solid dosage blister packaging types in the U.S., 2024 (volume percentage share %)
Figure 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
Figure 24 Oral solid dosage contract manufacturing market: Product type movement analysis
Figure 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
Figure 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
Figure 32 Immediate release contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Delayed release contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Controlled release contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
Figure 36 Oral solid dosage contract manufacturing market: End-use movement analysis
Figure 37 Large size companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Medium & small size companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Regional market: Key takeaways
Figure 41 Regional outlook, 2024 & 2030
Figure 42 Regional outlook, 2024 & 2030
Figure 43 North America market, 2018 - 2030 (USD Million)
Figure 44 Key country dynamics
Figure 45 U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Key country dynamics
Figure 47 Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Key country dynamics
Figure 50 UK oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Key country dynamics
Figure 52 Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Key country dynamics
Figure 54 France oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Key country dynamics
Figure 64 Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 China oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 Regulatory bodies in India involved in pharmaceutical regulations
Figure 70 India oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Key country dynamics
Figure 72 Clinical trial authorization process in Japan
Figure 73 Clinical Research of Medical Products in Japan
Figure 74 Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Key country dynamics
Figure 78 Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Clinical trial approval process in South Korea
Figure 81 South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Key country dynamics
Figure 83 Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 85 Key country dynamics
Figure 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 87 Key country dynamics
Figure 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Key country dynamics
Figure 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Key country dynamics
Figure 97 Clinical trial authorization process UAE
Figure 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Figure 99 Key country dynamics
Figure 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

The major companies featured in this Oral Solid Dosage Contract Manufacturing market report include:
  • Catalent Inc.
  • Lonza
  • Aenova Group
  • Boehringer Ingelheim International GmbH
  • Jubilant Pharmova Limited
  • Patheon Pharma Services
  • Recipharm AB.
  • Corden Pharma International
  • Siegfried Holding AG
  • Piramal Pharma Solutions
  • AbbVie Contract Manufacturing
  • Next Pharma AB

Table Information

Report AttributeDetails
No. of Pages178
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 38.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.72 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market by Form Type, Therapeutic Area, Application, Stage, Customer Type - Global Forecast to 2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market by Form Type, Therapeutic Area, Application, Stage, Customer Type - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing - Global Strategic Business Report - Product Image

Oral Solid Dosage Contract Manufacturing - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast to 2030 - Product Image

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.